International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 5, Issue:9, September, 2016

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : /
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2016.5(9): 801-815

Comparative Study between Febuxostat and Allupurinol based on Safety and Urate-Lowering Efficacy in Gout Patients of Indian Population
Shikhar Tyagi*, Shalini Rawat and Sarika Saxena
Amity Institute of Biotechnology, Amity University, Sector-125, Noida, UP, India
*Corresponding author

Gout is an ataxia evident as a continuum of medical and pathologic portions developed as an establishment when the body has surplus amounts of uric acid, appearing bit by bit by hyperuricemia. This is often depicted by serum urate levels greater than either 6.8 or 7.0 mg/dl. Gout can additionally show up as perpetual joint irritation of 1 or more joints. Gout is typical provocative joint exacerbation connected with essential co-morbidities including hypertension, renal impedance, cardiovascular ailment, weight and Type 2 diabetes.  Age, sex, genetic and race-related risks, diet (especially purine rich substances) and a number of pharmaceuticals (thiazide, loop diuretics, ACE inhibitors, and beta blockers) have been found as hazardous variables for improvement of Gout.  Gout occurs more in men than ladies and rarely happens in premenopausal Women. Uricostatic drugs (Xanthine oxidase inhibitors) are extensively and most commonly used for the treatment of chronic gout. This study is planned to look at the adequacy of two uric acid chopping down medications (Febuxostat and Allopurinol) for giving symptomatic pain relief and overhauling the utilitarian condition of the patients. Administration of Febuxostat and Allopurinol in Gout patients has emerged to be clinically effective in lowering down the uric acid levels as well as providing symbolic suitable deprivation of pain. In the perspective of undeniable statistical information, we consider that febuxostat should serve as primary choice of drug if early essential and considerable symptomatic improvements are taken into consideration.

Keywords: Febuxostat, Allopurinol,Gout,Uric acid, Uricostatic drugs, Hyperuricemia, Xanthine Oxidase.

Download this article as Download

How to cite this article:

Shikhar Tyagi, Shalini Rawat, Sarika Saxena. 2016. Comparative Study between Febuxostat and Allupurinol based on Safety and Urate-Lowering Efficacy in Gout Patients of Indian Population.Int.J.Curr.Microbiol.App.Sci. 5(9): 801-815. doi:
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.